InSitu Biologics, Inc.
PrivateLast Round
Seed Round
Aug 10, 2026
Est. Valuation
$34M
Total Funding Raised
$10M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
InSitu Biologics, Inc. is a biotechnology company that develops a multi-phase prolonged-release drug delivery platform for the localized treatment of pain, cancer, and infection.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InSitu Biologics, Inc. Comparables
Compare InSitu Biologics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Concentric Analgesics | 84% | |
| Sustained Therapeutics | 84% | |
| AmacaThera | 83% |
InSitu Biologics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Aug 10, 2026 | ||||
| Series A | Dec 28, 2021 | ||||
| Corporate Funding | Jul 31, 2018 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 10, 2026
$1.25M seed round completed.
- Jul 24, 2026
Monthly visitors increased 59% MoM.
InSitu Biologics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about InSitu Biologics, Inc.'s valuation, stock price, and market status.
Is InSitu Biologics, Inc. a public or private company?
InSitu Biologics, Inc. is a private company.
What is the current stock price of InSitu Biologics, Inc.?
InSitu Biologics, Inc. is a private company with no public stock price. Caplight tracks InSitu Biologics, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is InSitu Biologics, Inc. worth (valuation)?
InSitu Biologics, Inc.'s valuation is estimated at $34.0M based on funding round data.
Can I buy InSitu Biologics, Inc. stock?
InSitu Biologics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was InSitu Biologics, Inc.'s last funding round?
InSitu Biologics, Inc.'s most recent funding round was Seed Round on July 31, 2018.
Who are the main investors in InSitu Biologics, Inc.?
Investor information for InSitu Biologics, Inc. is not publicly disclosed.
Will InSitu Biologics, Inc. IPO soon?
No public IPO plans have been announced for InSitu Biologics, Inc..
How can I track InSitu Biologics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor InSitu Biologics, Inc.'s secondary market activity and sign up for updates.